PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 27.95 CHF 4.1% Market Closed
Market Cap: 921.9m CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

PolyPeptide Group AG
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PolyPeptide Group AG
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
PolyPeptide Group AG
SIX:PPGN
Revenue
€324.9m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Revenue
CHf577.8m
CAGR 3-Years
8%
CAGR 5-Years
14%
CAGR 10-Years
13%
Siegfried Holding AG
SIX:SFZN
Revenue
CHf1.3B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Revenue
CHf6.7B
CAGR 3-Years
19%
CAGR 5-Years
4%
CAGR 10-Years
6%
Tecan Group AG
SIX:TECN
Revenue
CHf1B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Revenue
CHf320m
CAGR 3-Years
19%
CAGR 5-Years
119%
CAGR 10-Years
N/A
No Stocks Found

PolyPeptide Group AG
Glance View

Market Cap
921.9m CHF
Industry
Life Sciences Tools & Services

PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.

PPGN Intrinsic Value
24.99 CHF
Overvaluation 11%
Intrinsic Value
Price

See Also

What is PolyPeptide Group AG's Revenue?
Revenue
324.9m EUR

Based on the financial report for Dec 31, 2023, PolyPeptide Group AG's Revenue amounts to 324.9m EUR.

What is PolyPeptide Group AG's Revenue growth rate?
Revenue CAGR 5Y
12%

Over the last year, the Revenue growth was 15%. The average annual Revenue growth rates for PolyPeptide Group AG have been 13% over the past three years , 12% over the past five years .

Back to Top